Header cover image

Hong Kong Pharmaceuticals & Biotech Top Growth Stocks

Results

5

1 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

5 companies

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$96.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$417.60

7D

-7.0%

1Y

119.8%

Cutia Therapeutics

Market Cap: HK$2.2b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$6.03

7D

-2.3%

1Y

-16.6%

Innovent Biologics

Market Cap: HK$143.1b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

New

1801

HK$83.65

7D

-10.6%

1Y

119.6%

InnoCare Pharma

Market Cap: HK$26.5b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

9969

HK$13.58

7D

-6.0%

1Y

111.2%

CanSino Biologics

Market Cap: HK$13.4b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$37.72

7D

-2.2%

1Y

17.7%